EAGLE PHARMACEUTICALS INC (EGRX)
US2697961082 - Common Stock
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 15.40M | 55.30M | 97.70M | 103.20M | 109.80M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 116.30M | 73.40M | 41.10M | 51.10M | 48.00M | |||
| Inventories | 42.50M | 47.80M | 21.90M | 8.10M | 6.60M | |||
| Other Current Assets | 13.10M | 12.20M | 11.90M | 3.70M | 15.10M | |||
| Total Current Assets | 187.30M | 188.80M | 172.60M | 166.10M | 179.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.00M | 1.20M | 1.60M | 2.10M | 5.90M | |||
| Goodwill | 45.00M | 45.00M | 39.70M | 39.70M | 39.70M | |||
| Intangibles | 107.40M | 118.30M | 10.70M | 12.90M | 15.60M | |||
| Other Non-Current Assets | 64.10M | 52.90M | 29.10M | 32.40M | 13.90M | |||
| Total Non-Current Assets | 217.50M | 217.40M | 81.10M | 87.10M | 75.20M | |||
| TOTAL ASSETS | 404.80M | 406.20M | 253.70M | 253.20M | 254.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 8.30M | 6.30M | 25.60M | 8.00M | 5.00M | |||
| Accrued Expenses | 61.30M | 61.60M | 32.30M | 23.80M | 28.40M | |||
| Accounts Payable | 15.80M | 19.00M | 16.40M | 6.30M | 5.50M | |||
| Other Current Liabilities | 1.20M | 24.20M | N/A | N/A | N/A | |||
| Total Current Liabilities | 86.60M | 111.10M | 74.40M | 38.10M | 38.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 61.90M | 56.20M | 0.00 | 25.10M | 33.60M | |||
| Other Non-Current Liabilities | 4.30M | 5.30M | 2.90M | 4.00M | 3.00M | |||
| Total Non-Current Liabilities | 66.20M | 61.50M | 2.90M | 29.10M | 36.60M | |||
| TOTAL LIABILITIES | 152.80M | 172.60M | 77.30M | 67.20M | 75.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 122.40M | 111.50M | 75.90M | 84.50M | 72.50M | |||
| Additional Paid In Capital | 373.80M | 366.30M | 325.80M | 305.40M | 278.50M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -243.10M | -243.10M | -225.10M | -203.90M | -171.90M | |||
| Other Shareholders' Equity | -1.10M | -1.10M | -100.00K | N/A | N/A | |||
| Shares Outstanding | 13.10M | 13.00M | 12.80M | 13.10M | 13.60M | |||
| Tangible Book Value per Share | 7.60 | 5.41 | 9.85 | 10.18 | 9.11 | |||
| Total Shareholders' Equity | 252.00M | 233.60M | 176.50M | 186.00M | 179.20M | |||
| TOTAL LIABILITIES AND EQUITY | 404.80M | 406.20M | 253.70M | 253.20M | 254.60M | |||
| Statistics | ||||||||
| Debt/Equity | 0.25 | 0.24 | N/A | 0.13 | 0.19 | |||
| Current Ratio | 2.16 | 1.70 | 2.32 | 4.36 | 4.62 | |||
| Return On Assets (ROA) | 2.99% | 8.76% | -3.39% | 4.74% | 5.62% | |||
| Return On Equity (ROE) | 4.80% | 15.24% | -4.87% | 6.45% | 7.98% | |||
| Return On Invested Capital (ROIC) | 10.53% | 27.41% | 1.23% | 12.12% | 7.98% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 11.06% | 33.73% | 2.71% | 23.30% | 16.25% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 22.27% | 105.75% | 7.09% | 43.96% | 33.97% | |||
All data in USD , ROIC based on taxRate of 0.21